Basilea Pharmaceutica
BSLN.SW
#6651
Rank
NZ$1.37 B
Marketcap
NZ$110.99
Share price
0.57%
Change (1 day)
-3.64%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2025: NZ$0.10 Billion

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are NZ$0.29 Billion. In 2025 the company made an earning of NZ$0.10 Billion a decrease over its 2024 earnings that were of NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2025

Annual earnings

Year Earnings Change
2025NZ$0.10 B-13.15%
2024NZ$0.11 B436.2%
2023NZ$21.48 M-5.02%
2022NZ$22.62 M-276.18%
2021-NZ$12.84 Million-55.31%
2020-NZ$28.73 Million-28%
2019-NZ$39.91 Million-27.06%
2018-NZ$54.71 Million62.13%
2017-NZ$33.75 Million-60.94%
2016-NZ$86.38 Million-19.67%
2015-NZ$0.11 Billion48.25%
2014-NZ$72.53 Million12.95%
2013-NZ$64.22 Million-35.16%
2012-NZ$99.04 Million-5.75%
2011-NZ$0.11 Billion-152.57%
2010NZ$0.19 B-199.59%
2009-NZ$0.21 Billion-15.54%
2008-NZ$0.24 Billion22.84%
2007-NZ$0.2 Billion60.07%
2006-NZ$0.13 Billion85.69%
2005-NZ$65.09 Million-43.04%
2004-NZ$0.12 Billion47.04%
2003-NZ$77.72 Million-37.99%
2002-NZ$0.13 Billion